Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
8.79 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 124.968 | 230.784 | 85.262 | 284.309 | 43.728 | 27.332 |
| Short Term Investments
| 406.752 | 135.563 | 257.007 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 531.72 | 366.347 | 342.269 | 284.309 | 43.728 | 27.332 |
| Net Receivables
| 13.876 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 3.321 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 13.413 | 8.927 | 5.605 | 5.059 | 1.343 | 0.007 |
| Total Current Assets
| 562.33 | 375.274 | 347.874 | 289.368 | 45.071 | 27.339 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 4.707 | 0.56 | 0.719 | 0.284 | 0.483 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 15.63 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 15.63 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.121 | 0.214 | 0.469 | 0.169 | 0.107 | 0 |
| Total Non-Current Assets
| 20.458 | 0.774 | 1.188 | 0.453 | 0.59 | 0 |
| Total Assets
| 582.788 | 376.048 | 349.062 | 289.821 | 45.661 | 27.339 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3.262 | 2.576 | 0.26 | 1.744 | 0.202 | 0.069 |
| Short Term Debt
| 0.01 | 0.408 | 0.81 | 0.408 | 0.198 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.554 | 0 | 0 | 6.605 | 1.569 | 0 |
| Other Current Liabilities
| 68.625 | 26.524 | 15.545 | 6.505 | 1.596 | 1.952 |
| Total Current Liabilities
| 73.451 | 29.508 | 16.615 | 8.657 | 1.996 | 2.021 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 2.592 | 0 | 0.408 | 0.016 | 0.204 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.994 | 0 | 0 | 0 | 91.964 | 30.504 |
| Total Non-Current Liabilities
| 6.586 | 0 | 0.408 | 0.016 | 92.168 | 30.504 |
| Total Liabilities
| 80.037 | 29.508 | 17.023 | 8.673 | 94.164 | 32.525 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 5.702 | 5.487 |
| Common Stock
| 0.01 | 0.009 | 0.007 | 0.006 | 2 | 2 |
| Retained Earnings
| -554.081 | -458.585 | -269.668 | -127.487 | -56.842 | -12.784 |
| Accumulated Other Comprehensive Income/Loss
| 0.084 | 0.009 | -0.071 | 0 | 0.001 | 0 |
| Other Total Stockholders Equity
| 1,056.738 | 805.107 | 601.771 | 408.629 | 92.601 | -5.376 |
| Total Shareholders Equity
| 502.751 | 346.54 | -269.668 | -127.487 | -54.205 | -10.673 |
| Total Equity
| 502.751 | 346.54 | -269.668 | 162.334 | -48.503 | -5.186 |
| Total Liabilities & Shareholders Equity
| 582.788 | 376.048 | -252.645 | -118.814 | 45.661 | 27.339 |